| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 9, 2007
Accepted on May 22, 2008
Reproductive Sciences Section, Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester Royal Infirmary, Leicester, LE2 7LX, United Kingdom; Department of Cell Physiology and Pharmacology, Henry Wellcome Building, University of Leicester, Leicester, LE1 9HN, United Kingdom
* To whom correspondence should be addressed. E-mail: jmw23{at}le.ac.uk.
Histamine stimulates uterine contraction, however little is known regarding the mechanism or regulation of uterine histamine receptor signaling. Here we investigated the regulation of G
q/11-coupled histamine receptor signaling in human myometrial smooth muscle cells using the inositol 1,4,5-trisphosphate (IP3) biosensor eGFP-PHPLC
and the Ca2+-sensitive dye Fluo-4. Histamine addition caused concentration-dependent increases in IP3 and [Ca2+]i in the ULTR human uterine smooth muscle cell line and primary human myometrial cells. These effects were completely inhibited by the H1 histamine receptor antagonist, diphenhydramine, and were unaffected by the H2 histamine receptor antagonist, cimetidine. ULTR and primary myometrial cells were transfected with either dominant-negative G protein-coupled receptor kinases (GRKs) or siRNAs targeting specific GRKs to assess the roles of this protein kinase family in H1 histamine receptor desensitization. Dominant-negative GRK2, but not GRK5 or GRK6, prevented H1 histamine receptor desensitization. Similarly, transfection with siRNAs (that each caused > 70% depletion of the targeted GRK) for GRK2, but not GRK3 or GRK6, also prevented H1 histamine receptor desensitization. Our data suggest that histamine stimulates phospholipase C-signaling in myometrial smooth muscle cells through H1 histamine receptors and that GRK2 recruitment is a key mechanism in the regulation of H1 histamine receptor signaling in human uterine smooth muscle. These data provide insights into the in situ regulation of this receptor subtype and may inform pathophysiological functioning in pre-term labor and other conditions involving uterine smooth muscle dysregulation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |